When to Switch Therapy in Patients with Severe Community-Acquired Pneumonia
- Alpesh N. Amin, MD, MBA; and
- Michael J. Pistoria, DO
- From University of California, Irvine, CA 92868, and Lehigh Valley Hospital, Allentown, PA 18105.
IN RESPONSE:
We thank Dr. Mortensen and colleagues for their recent letter in regards to our Update in Hospital Medicine, which referred to the article by Oosterheert and colleagues (1). We acknowledge that the original trial by Oosterheert and colleagues has potential limitations (some of which were listed by Dr. Mortensen and colleagues), but the concept of switching from intravenous to oral therapy has been documented in the literature as a strategy for care in community-acquired pneumonia. The 2007 combined American Thoracic …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
